Discontinuation report REFRESH REDNESS RELIEF
Report ID | 173240 |
Drug Identification Number | 02315920 |
Brand name | REFRESH REDNESS RELIEF |
Common or Proper name | naphazoline ophthalmic sol 0.1% |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NAPHAZOLINE HYDROCHLORIDE |
Strength(s) | 0.1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 15ml |
ATC code | S01GA |
ATC description | DECONGESTANTS AND ANTIALLERGICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-11-01 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-11-02 | English | Compare |
v2 | 2022-11-01 | French | Compare |
v1 | 2022-11-01 | English | Compare |
Showing 1 to 3 of 3